NIH-funded research R01 grant

Understanding how the NLRP3 inflammasome is activated

Official title: Elucidating the functional mechanism of NLRP3 inflammasome activation

Funded at Boston Children's Hospital · NIH-11041081 · Data updated 2026-11-12

This study is looking at a part of your immune system called the NLRP3 inflammasome to understand how it causes inflammation and cell damage, which could help us learn more about diseases like Alzheimer's and other age-related issues, ultimately aiming to find new ways to help patients feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 26, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$708,000
NIH project number5R01AI177778-03
Project IDNIH-11041081 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other aging-related disorders characterized by inflammation.

Less likely to help

Patients with non-aging related conditions or those not experiencing significant inflammation may not benefit from this research.

What this research studies

This research investigates the NLRP3 inflammasome, a key component of the innate immune system that can trigger inflammation and cell death in response to various stress signals. By examining how NLRP3 is activated, the research aims to uncover its role in diseases such as Alzheimer's and other aging-related disorders. The approach involves studying the molecular interactions and mechanisms that lead to inflammasome activation, which could provide insights into potential therapeutic targets. Patients may benefit from a better understanding of how inflammation contributes to their conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce inflammation and improve outcomes for patients with Alzheimer's and related diseases.

How similar studies have gone: Previous research has shown that targeting inflammasome pathways can be effective in treating inflammatory diseases, suggesting a promising avenue for this investigation.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Wu, Hao — Boston Children's Hospital
  • Study coordinator: Wu, Hao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.